CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

ORIC Pharmaceuticals Starts Phase 3 Trial of Rinzimetostat in Metastatic Prostate Cancer

Phase 3RinzimetostatPositive
AI Analysis

Summary

ORIC Pharmaceuticals has initiated a Phase 3 clinical trial of rinzimetostat for the treatment of metastatic prostate cancer.

Clinical Trial Data

Phase

Phase 3

Importance:6/10
Sentiment:
0.30
Phase 3OncologyProstate CancerTrial Initiation
Related Companies

Read the original article

Published by yahoo_finance on July 14, 2026 9:07 PM

Read Original